UNITY Biotechnology to Participate in Upcoming September Investor Conferences September 4, 2020 at 8:00 AM EDT PDF Version SAN FRANCISCO, Sept. 04, 2020 (GLOBE NEWSWIRE) -- UNITY Biotechnology (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that members of its senior management team will participate in the following upcoming September investor conferences: Citi 15th Annual BioPharma Virtual ConferenceDate: September 9, 2020Location: Virtual – 1x1 only Morgan Stanley 18th Annual Global Healthcare ConferenceDate: September 15, 2020Fireside Chat Time: 4:15 PM E.T.Location: Virtual Cantor Fitzgerald Virtual Healthcare Conference ConferenceDate: September 16, 2020Presentation Time: 10:00 AM E.T.Location: Virtual A live audio webcast of the fireside chat and presentation from the Morgan Stanley and Cantor Fitzgerald conferences will be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following each event. About UNITYUNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY's initial focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related diseases, such as osteoarthritis, eye diseases, neurological diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter. Investors Endurance Advisors Mike Zanoni mzanoni@enduranceadvisors.com Media Canale Communications Jason Spark jason@canalecomm.com Source: Unity Biotechnology, Inc.
